✦ LIBER ✦

Concordant KRAS Mutations in Primary and Metastatic Colorectal Cancer Tissue Specimens: A Meta-Analysis and Systematic Review

✍ Scribed by Han, Cheng-Bo; Li, Fan; Ma, Jie-Tao; Zou, Hua-Wei

Book ID: 120568675
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 694 KB
Volume: 30
Category: Article
ISSN: 0735-7907
DOI: 10.3109/07357907.2012.732159

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations of KRAS and BRAF in Primary an

Mutations of KRAS and BRAF in Primary and Matched Metastatic Sites of Colorectal Cancer

✍ Artale, S.; Sartore-Bianchi, A.; Veronese, S. M.; Gambi, V.; Sarnataro, C. S.; G 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 68 KB

KRAS p.G13D mutation and codon 12 mutati

KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer : A systematic review and meta-analysis

✍ Chen Mao; Ya-Fang Huang; Zu-Yao Yang; Da-Yong Zheng; Jin-Zhang Chen; Jin-Ling Ta 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB

Predictive and prognostic value of KRAS

Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies

✍ Li-Xin Qiu; Chen Mao; Jian Zhang; Xiao-Dong Zhu; Ru-Yan Liao; Kai Xue; Jin Li; Q 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 154 KB

PIK3CA exon 20 mutations as a potential

PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis

✍ Mao, C.; Yang, Z. Y.; Hu, X. F.; Chen, Q.; Tang, J. L. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 552 KB

KRAS mutation does not predict the effic

KRAS mutation does not predict the efficacy of neo-adjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis

✍ Clancy, Cillian; Burke, John P.; Coffey, J. Calvin 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 965 KB

A systematic review and meta-analysis of

A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancer

✍ Barbara-Ann Adelstein; Timothy A. Dobbins; Carole A. Harris; Ian C. Marschner; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 689 KB